CODEX Archives | Certara

On-Demand Webinar

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar]

Vice President, Quantitative Science Services, Certara Matt advances the integration of published clinical outcomes data…

CertaraApril 3, 2025

Fact Sheet

CODEX Atopic Dermatitis (ADERM) Database

CertaraFebruary 19, 2025

Fact Sheet

CODEX Psoriasis (PSO) Database

CertaraFebruary 19, 2025

Fact Sheet

CODEX Alzheimer’s Disease (AD) Database

CertaraFebruary 19, 2025

Fact Sheet

CODEX Relapsed and Refractory Multiple Myeloma (RRMM) Database

CertaraFebruary 19, 2025

Publication

INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease

The Phase 1 INTERCEPT-AD study evaluated sabirnetug (ACU193), a monoclonal antibody targeting amyloid-beta oligomers (AβOs),…

CertaraJanuary 8, 2025

Press Coverage

Adopting the Power of AI to Drug Development Projects: Making go/no-go decisions with MBMA and CODEx Clinical Outcome database

CertaraJune 26, 2024

Case Study

Repurposing Data & Advanced Analytics to Validate Surrogate Endpoints

Repurposed data and advanced analytics can be used to validate a surrogate endpoint. A surrogate…

CertaraApril 13, 2023

© 2025 Certara. All Rights Reserved. | Privacy policy